Clinical trial
Endpoint Determination Study for An Antibody Guided Dietary Restriction Trial Using Biomerica InFoods® IBS Test in Patients With a Previous Diagnosis of Irritable Bowel Syndrome (IBS)
NCT03459482 is registered in ClinicalTrials.gov with Biomerica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endpoint Determination Study for An Antibody Guided Dietary Restriction Trial Using Biomerica InFoods® IBS Test in Patients With a Previous Diagnosis of Irritable Bowel Syndrome (IBS)
- Lead sponsor
- Biomerica
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 21, 2018
- Completion date
- December 31, 2021
- Enrollment
- 556 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.